First Nebraska Trust Co Takes Position in Colgate-Palmolive Company $CL

First Nebraska Trust Co bought a new stake in shares of Colgate-Palmolive Company (NYSE:CLFree Report) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 60,532 shares of the company’s stock, valued at approximately $5,159,000.

Several other institutional investors and hedge funds have also bought and sold shares of CL. Kemnay Advisory Services Inc. purchased a new position in Colgate-Palmolive in the 4th quarter worth approximately $25,000. CBIZ Investment Advisory Services LLC boosted its stake in shares of Colgate-Palmolive by 86.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 323 shares of the company’s stock valued at $26,000 after purchasing an additional 150 shares during the period. TD Capital Management LLC grew its holdings in shares of Colgate-Palmolive by 61.4% in the fourth quarter. TD Capital Management LLC now owns 326 shares of the company’s stock worth $26,000 after purchasing an additional 124 shares during the last quarter. Triumph Capital Management grew its holdings in shares of Colgate-Palmolive by 62.9% in the fourth quarter. Triumph Capital Management now owns 329 shares of the company’s stock worth $26,000 after purchasing an additional 127 shares during the last quarter. Finally, Jessup Wealth Management Inc purchased a new position in shares of Colgate-Palmolive in the fourth quarter worth $26,000. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive News Roundup

Here are the key news stories impacting Colgate-Palmolive this week:

  • Positive Sentiment: Second-quarter adjusted/base-business EPS was $0.99, exceeding the $0.95 consensus estimate and rising from $0.92 a year earlier. Revenue increased 4.9% year over year to $5.36 billion, in line with expectations. Colgate-Palmolive Q2 Earnings and Revenues Top Estimates
  • Positive Sentiment: Profitability improved, with GAAP and base-business gross margins expanding 140 basis points to 61.5%. Productivity gains and organic sales growth helped offset increased brand investment, while Latin America led regional growth and toothpaste maintained its global leadership. Colgate Q2 Earnings Beat Estimates on Strong Margins
  • Neutral Sentiment: Management reaffirmed its full-year sales forecast, with expected revenue of approximately $20.8 billion to $21.6 billion. Maintaining guidance supports stability, but the range signals limited visibility in a choppy consumer environment. Colgate-Palmolive Reaffirms Annual Sales Forecast
  • Negative Sentiment: North American demand remained muted, creating concern that the company’s strongest international performance may not fully offset weakness in its largest developed market. Investors also focused on management’s warning that new tariffs could outweigh a recent refund benefit, potentially pressuring future earnings. Colgate Warns New Tariffs Will Outweigh Recent Refund Windfall
  • Negative Sentiment: GAAP EPS declined 5% to $0.86 despite the adjusted earnings beat, and organic sales growth was only 2.4%. The combination of slower underlying growth, domestic weakness and tariff risk is outweighing the quarter’s positive margin and earnings performance.

Colgate-Palmolive Stock Performance

NYSE:CL opened at $91.29 on Friday. The stock has a market cap of $73.05 billion, a P/E ratio of 36.23, a price-to-earnings-growth ratio of 4.81 and a beta of 0.33. The firm’s fifty day simple moving average is $90.97 and its 200 day simple moving average is $89.44. Colgate-Palmolive Company has a twelve month low of $74.54 and a twelve month high of $99.33. The company has a quick ratio of 0.67, a current ratio of 1.02 and a debt-to-equity ratio of 16.33.

Colgate-Palmolive (NYSE:CLGet Free Report) last issued its quarterly earnings data on Friday, July 31st. The company reported $0.99 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.95 by $0.04. Colgate-Palmolive had a net margin of 10.04% and a return on equity of 386.76%. The business had revenue of $5.36 billion for the quarter, compared to the consensus estimate of $5.36 billion. During the same period in the previous year, the firm earned $0.92 EPS. The company’s quarterly revenue was up 4.9% compared to the same quarter last year. As a group, research analysts predict that Colgate-Palmolive Company will post 3.82 EPS for the current year.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, August 14th. Investors of record on Monday, July 20th will be given a dividend of $0.53 per share. The ex-dividend date is Monday, July 20th. This represents a $2.12 annualized dividend and a dividend yield of 2.3%. Colgate-Palmolive’s payout ratio is currently 82.49%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the stock. Royal Bank Of Canada reissued an “outperform” rating and set a $102.00 price target on shares of Colgate-Palmolive in a research report on Monday, May 4th. Bank of America decreased their price objective on shares of Colgate-Palmolive from $105.00 to $102.00 and set a “buy” rating on the stock in a research report on Friday, April 10th. Rothschild & Co Redburn set a $100.00 price objective on shares of Colgate-Palmolive and gave the company a “buy” rating in a research note on Tuesday, April 21st. Sanford C. Bernstein initiated coverage on shares of Colgate-Palmolive in a report on Thursday, June 11th. They set a “market perform” rating and a $96.00 target price for the company. Finally, UBS Group raised their target price on Colgate-Palmolive from $100.00 to $106.00 and gave the stock a “buy” rating in a research note on Thursday, July 16th. Twelve equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $97.82.

Read Our Latest Analysis on Colgate-Palmolive

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.

Featured Articles

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.